Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study

References

• Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333:853–61
   PubMed Web of Science ®Google Scholar
• De Leo V, La Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 2003; 24:633–67
   PubMed Web of Science ®Google Scholar
• Oláh KS. The modern management of hirsutism. Rev Gynaecol Practice 2004;4:211–20
   Google Scholar
• The Endocrine Society’s Clinical Guidelines. Evaluation & Treatment of Hirsutism in Premenopausal Women: an Endocrine Society Clinical Practice Guideline. J Clin Endocr Metab 2008;93:1105-20
   PubMed Web of Science ®Google Scholar
• Murphy AA, Cropp CS, Smith BS, et al. Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in non-hirsute women. Fertil Steril 1990;53:35–9
   PubMed Web of Science ®Google Scholar
• van der Vange N, Blankenstein MA, Kloosterboer HJ, et al. Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception 1990;41:345–52
   PubMed Web of Science ®Google Scholar
• Jung-Hoffmann C, Kuhl H. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone. Am J Obstet Gynecol 1987;156:199–203
   PubMed Web of Science ®Google Scholar
• Azziz R, Gay F. The treatment of hyperandrogenism with oral contraceptives. Semin Reprod Endocrinol 1989;7:246–54
   Google Scholar
• Dewis P, Petsos P, Newman M, Anderson DC. The treatment of hirsutism with a combination of desogestrel and ethinyl oestradiol. Clin Endocrinol 1985;22:29–36
   PubMed Web of Science ®Google Scholar
• Azziz R. The evaluation and management of hirsutism. Obstet Gynecol 2003;101:995–1007
   PubMed Web of Science ®Google Scholar
• Alsina JC. After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives. Eur J Contracept Reprod Health Care 2010;15:1–3
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. Pharmacological profile of progestins. Maturitas 2008;61:151–7
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Nath A. The use of newer progestins for contraception. Contraception 2010;82:410–7
   PubMed Web of Science ®Google Scholar
• Bitzer J. The importance of antiandrogenicity of progestogens. Gynaecol Forum 2009;14:21–3
   Google Scholar
• Mueck AO, Seeger H. Pharmacology of dienogest. Gynaecol Forum 2009;14:9–12
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• Ramli R, Malik AS, Hani AFM, Jamil A. Acne analysis, grading and computational assessment methods: an overview. Skin Res Technol 2012;18:1–14
   PubMed Web of Science ®Google Scholar
• Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998;134:454–8
   PubMed Web of Science ®Google Scholar
• Palombo-Kinne E, Schellschmidt I, Schumacher U, Gräser T. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate. Contraception 2009;79:282–99
   PubMed Web of Science ®Google Scholar
• van Vloten WA, van Haselen CW, van Zuuren EJ, et al. The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis 2002;69:2–15
   PubMedGoogle Scholar
• Caruso S, Agnello C, Romano M, et al. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life. J Sex Med 2011;8:2841–50
   PubMed Web of Science ®Google Scholar
• Guida M, Bifulco G, Di Spiezio Sardo A, et al. Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill. Int J Womens Health 2010;2:279–90
   PubMedGoogle Scholar
• Wiegratz I, Jung-Hoffmann C, Kuhl H. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception 1995;51:341–6
   PubMed Web of Science ®Google Scholar
• Arrington EA, Patel NS, Gerancher K, Feldman SR. Combined oral contraceptives for the treatment of acne: a practical guide. Cutis 2012;90:83–90
   PubMed Web of Science ®Google Scholar
• Del Marmol V, Teichmann A, Gertsen K. The role of combined oral contraceptives in the management of acne and sebborhea. Eur J Contracep Reprod Health Care 2004;9:107–24
   PubMed Web of Science ®Google Scholar